188
Sherstyuk et al.
1
previously.26 TLC Rf 0.38 (MeOH:DCM, 0.5:9.5); H NMR (400 MHz, CDCl3): d 7.47
(4H, dt, J ¼ 7.4, 1.5, oH-Ar), 7.39 (2H, dt, J ¼ 8.9, 2.1, mH-Ar), 7.28 (4H, tt, J ¼ 7.1,
1.4, mH-Ar), 7.19 (2H, tt, J ¼ 7.3, 1.5, pH-Ar), 6.82 (2H, dt, J ¼ 8.9, 1.9, oH-Ar), 3.78
(3H, s, CH3O), 3.70 (2H, br.t, J ¼ 4.6, CH2OH), 3.62 (2H, t, J ¼ 5.4, OCH2CH2O), 3.50
(2H, br.t, J ¼ 4.8, NHCH2CH2O), 2.38 (2H, t, J ¼ 5.3, NHCH2); 13C NMR (100 MHz,
CDCl3): d 157.96 (MMTr), 146.34 (MMTr), 138.24 (MMTr), 129.92 (MMTr), 128.67
(MMTr), 127.93 (MMTr), 126.34 (MMTr), 72.02 (NHCH2CH2O), 71.39
(OCH2CH2OH), 70.35 (MMTr), 61.92 (OCH2CH2OH), 55.28 (CH3O-MMTr),
43.45 (NHCH2CH2O).
2-(2-N-Trifluoroacetylaminoethoxy)ethanol (12)
2-(2-Aminoethoxy)ethanol (1) (0.5 mL, 5 mmol) was dissolved in MeOH (5 mL). The
solution of ethyl trifluoroacetate (0.45 mL, 6 mmol) in MeOH (2.5 mL) and Et3N
(0.7 mL, 5 mmol) were added to the solution under intensive stirring at room tempera-
ture. After 3 h, the reaction mixture was evaporated. The protected amino alcohol was
purified by silica gel chromatography in a gradient of MeOH (0!10%) in DCM. The
appropriate fractions were evaporated to give after drying 0.8 g of target compound 12
(4 mmol, yield 80%). NMR data were in agreement with those reported previously.28
1
TLC Rf 0.6 (EtOH:DCM, 1:9); H NMR (400 MHz, CDCl3): d 7.78 (1H, br.s, NH),
3.72 (2H, t, J ¼ 4.4, CH2OH), 3.62-3.49 (6H, m, OCH2CH2O, NHCH2CH2O, NHCH2),
3.22 (1H, br.s, OH); 13C NMR (100 MHz, CDCl3): d 157.75 (q, JCF ¼ 37.4, C ¼ O),
116.00 (q, JCF ¼ 287.2, CF3), 72.04 (NHCH2CH2O), 68.68 (OCH2CH2O), 61.36
(CH2OH), 39.63 (NHCH2); 19F NMR (CDCl3): d 85.81.
General Procedure for Monophosphorylation of Compounds 8 and 12
Protected amino alcohol 8 or 12 (1 mmol) was co-evaporated with dry pyridine
(3 ꢁ 3 mL) to dryness, than dissolved in dry pyridine (10 mL). The solution was cooled
in an ice bath. POCl3 (0.374 mL, 4 mmol) was added to the cold solution, and the reac-
tion mixture was stirred for 15 minutes. The reaction was quenched with 1 M TEAB
pH 7.5 (100 mL). After 1 h, the reaction mixture was evaporated. In the case of 12, the
target product 13 was purified by RPC in 0.1 M TEAB. The appropriate fractions were
evaporated to give after drying target phosphorylated compound 13 as its Et3N salt
(0.225 g, 0.8 mmol, yield 80%).
In the case of 8 the reaction mixture was separated by AEC in a linear gradient of
TEAB (0!0.6 M) in 40% aqueous EtOH. Monophosphate 10 was obtained as Et3N
salt (0.154 g, 0.4 mmol, yield 40%).
2-(2-N-Trifluoroacetylaminoethoxy)ethylphosphate (13)
1
TLC Rf 0.63 (iPrOH:conc.aq.NH3:H2O, 6:1:3); H NMR (300 MHz, D2O): d 4.01-3.94
(2H, m, CH2OP), 3.72 (4H, br.t, J ¼ 5.1, OCH2CH2OP, NHCH2CH2O), 3.55 (2H, t,
J ¼ 5.2, NHCH2), 3.19 (6H, q, J ¼ 7.3, CH2(Et3N)), 1.27 (9H, t, J ¼ 7.3, CH3(Et3N));
31P NMR (120 MHz, D2O): d 0.68; 19F NMR (280 MHz, D2O): d 87.44; MS ESI (m/z):
[M-H]- calcd. for C6H10F3NO6P, 280.02; found, 280.10; [2M-H]- calcd for
C12H21F6N2O12P2, 561.05; found, 561.19.